References of "Jaspart, Séverine"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailComparison of chitosan/siRNA and trimethylchitosan/siRNA complexes behaviour in vitro
Dehousse, Vincent ULg; Garbacki, Nancy ULg; Jaspart, Séverine ULg et al

in International Journal of Biological Macromolecules (2010), 46

Chitosan and trimethylchitosan (TMC)-siRNA nanoparticles were produced by simple complexation technique or by ionic gelation using tripolyphosphate (TPP). The obtained complexes were characterized in ... [more ▼]

Chitosan and trimethylchitosan (TMC)-siRNA nanoparticles were produced by simple complexation technique or by ionic gelation using tripolyphosphate (TPP). The obtained complexes were characterized in terms of physicochemical properties such as size, zeta potential, complexation efficiency and stability. Furthermore, cytotoxicity, cell uptake and transfection efficiency of polyplexes were evaluated in vitro. Under pH condition of cell culture medium, a strong decrease in siRNA condensation efficiency was observed with chitosan nanoparticles. This characteristic resulted in low transfection efficiencies in HEK293 cell line. Formulation of chitosan polyplexes with TPP led to improvement of polyplexes stability but no significant increase in transfection efficiency was observed compared to simple chitosan complexes. By contrast, TMC complexes did not have pH dependency on siRNA complexation. TMCsiRNA nanoparticles were stable in physiological condition. Accordingly, cellular uptake was increased compared to chitosan polyplexes. However, improvement of transfection efficiency was low regarding to cellular uptake of these complexes. Chitosan and TMC complexes present some characteristics favourable for siRNA delivery, such as ability to integrate siRNA into small discrete particles or low toxicity of the complexes. This study also highlights the importance of complexes stability in physiological environment for siRNA transfection purposes. [less ▲]

Detailed reference viewed: 84 (30 ULg)
Full Text
Peer Reviewed
See detailThe supercritical micronization of solid dispersions by Particles from Gas Saturated Solutions using experimental design
Brion, Michaël ULg; Jaspart, Séverine ULg; Perrone, Leonardo et al

in Journal of Supercritical Fluids (2009), 51(1), 50-56

The Particle from Gas Saturated Solutions process was successfully used to micronize solid dispersions containing hydrophilic carriers and a new chemical entity, YNS3107. By means of experimental design ... [more ▼]

The Particle from Gas Saturated Solutions process was successfully used to micronize solid dispersions containing hydrophilic carriers and a new chemical entity, YNS3107. By means of experimental design, the effects of several experimental parameters on micronization were investigated. Within the chosen experimental conditions, the results showed that the autoclave temperature, autoclave pressure, drug loading, flow rate of carbon dioxide and air pressure were significant parameters. During the optimization step, the most relevant parameters of the screening were optimized using a central composite design meanwhile other factors were kept constant. Optimal conditions were used to produce microparticles with a volume weighted mean diameter of 30.4 µm. The closeness between the measured and predicted response, evaluated at 28.1 µm, demonstrated the validity of the statistical analyses. Finally, an enhancement of the rate of dissolution of YNS3107 in the solid dispersion microparticles was measured using USP II dissolution test apparatus. [less ▲]

Detailed reference viewed: 118 (14 ULg)
Peer Reviewed
See detailUse of supercritical fluids technology (PGSS) for the production of betametazone loaded solid lipid microparticles
Nizet, Dominique; Jaspart, Séverine ULg; Brion, Michael et al

Poster (2008)

Detailed reference viewed: 59 (3 ULg)
Full Text
Peer Reviewed
See detailSolid lipid microparticles as a sustained release system for pulmonary drug delivery
Jaspart, Séverine ULg; Bertholet, Pascal; Piel, Géraldine ULg et al

in European Journal of Pharmaceutics & Biopharmaceutics (2007), 65(1), 47-56

The controlled release of drugs for pulmonary, delivery is a research field which has been so far rather unexploited but is currently becoming increasingly attractive. The introduction part of this ... [more ▼]

The controlled release of drugs for pulmonary, delivery is a research field which has been so far rather unexploited but is currently becoming increasingly attractive. The introduction part of this research article first details the potential advantages of solid lipid microparticles (SLMs) as drug carrier compared to liposomes and polymeric microspheres. The aim of this work is to use SLMs to impart a sustained release profile to a model drug, salbutamol acetonide (SA). SA was synthesized from salbutamol in order to increase the lipophilicity of this molecule and thereby to increase its incorporation efficiency into SLMs. SA-loaded SLMs were then produced by a hot emulsion technique followed by high-shear homogenisation and the manufacturing parameters were optimized using the experimental design methodology in order to reach a suitable particle size for pulmonary administration. Scanning electron micrographs showed that SLMs are spherical, have a smooth surface and that SA crystallises outside of the particles when the drug loading is higher than 20%. This was confirmed by X-ray diffraction. SA in vitro release study from SLMs showed that the release rate increased with SA loading but remained in every case lower than the dissolution rate of pure SA. (c) 2006 Elsevier B.V. All rights reserved. [less ▲]

Detailed reference viewed: 84 (22 ULg)
See detailSupercritical fluid technology to produce solid lipid microparticles
Nizet, Dominique; Jaspart, Séverine ULg; Brion, Michael et al

Conference (2007)

Detailed reference viewed: 22 (3 ULg)
Full Text
Peer Reviewed
See detailInhaled fluticasone reduces bronchial responsiveness and airway inflammation in cats with mild chronic bronchitis
Kirschvink, N; Leemans, Jérôme ULg; Delvaux, François et al

in Journal of Feline Medicine and Surgery (2006), 8(1), 45-54

This study investigated the effect of inhaled fluticasone on lower airway inflammation and bronchial responsiveness (BR) to inhaled carbachol in cats with very mild, chronic bronchitis (n = 5) that were ... [more ▼]

This study investigated the effect of inhaled fluticasone on lower airway inflammation and bronchial responsiveness (BR) to inhaled carbachol in cats with very mild, chronic bronchitis (n = 5) that were compared with healthy cats serving as controls (n = 6). Chest radiographs, BR tests performed non-invasively by barometric whole body plethysmography (BWBP) and bronchoalveolar lavage (BAL) were performed before and after treatment. BR was quantified by calculating the concentration of carbachol inducing bronchoconstriction (C-Penh300%), defined as a 300% increase of baseline Penh, an index of bronchoconstriction obtained by BWBP. BAL fluid was analyzed cytologically and the oxidant marker 8-iso-PGF2α was determined. At test 1, healthy cats and cats with bronchitis were untreated, whereas for test 2 inhalant fluticasone (250 μg once daily) was administrated for 2 consecutive weeks to cats with bronchitis. Control cats remained untreated. Inhaled fluticasone induced a significant increase in C-Penh300% and a significant decrease of BAL fluid total cells, macrophages, neutrophils and 8-iso-PGF2α in cats with bronchitis, whilst untreated control cats did not show significant changes over time. This study shows that a 2-week fluticasone treatment significantly reduced lower airway inflammation in very mild bronchitis. BR could be successfully monitored in cats using BWPB and decreased significantly in response to inhaled fluticasone. 8-Iso-PGF2α in BAL fluid was responsive to treatment and appeared as a sensitive biomarker of lower airway inflammation in cats. [less ▲]

Detailed reference viewed: 36 (5 ULg)
Peer Reviewed
See detailEncapsulation of the sunscreen agent, octyl dimethyl PABA, in lipid microparticles: effect on photostability
Tursilli, Rosanna; Scalia, Santo; Piel, Géraldine ULg et al

Poster (2006)

Detailed reference viewed: 32 (0 ULg)
Full Text
Peer Reviewed
See detailSolid Lipid Microparticles: Formulation, Preparation, Characterisation, Drug Release and Applications
Jaspart, Séverine ULg; Piel, Géraldine ULg; Delattre, Luc ULg et al

in Expert Opinion on Drug Delivery (2005), 2(1), 75-87

This review details the properties of solid lipid microparticles (SLMs): a promising drug carrier system that has been until now rather unexploited. First, the advantages of SLMs compared with other drug ... [more ▼]

This review details the properties of solid lipid microparticles (SLMs): a promising drug carrier system that has been until now rather unexploited. First, the advantages of SLMs compared with other drug carrier systems are listed. Then an overview of SLM manufacturing compounds and techniques is presented. A detailed discussion of the characteristics of SLMs follows, and includes the determination of particle size distribution, the determination of SLM morphology, the solid-state analysis, the determination of SLM drug loading and the factors influencing it. The in vitro drug release studies that have been carried out so far and the parameters affecting them are also described. Some preliminary in vivo aspects (in vivo drug release studies, biocompatibility studies and in vivo fate) are also considered. [less ▲]

Detailed reference viewed: 45 (3 ULg)
Peer Reviewed
See detailIn vitro release of salbutamol acetonide from solid lipid nanoparticles
Jaspart, Séverine ULg; Bodson, Cédric; Bertholet, Pascal et al

in Proceedings of 1st Pharmaceutical Sciences Fair and Exhibition (2005)

Detailed reference viewed: 31 (1 ULg)
Peer Reviewed
See detailSolid lipid Nanoparticles for administration by inhalation : Optimisation of manufacturing parameters
Jaspart, Séverine ULg; Bodson, Cédric; Bertholet, Pascal et al

Conference (2004)

Detailed reference viewed: 8 (2 ULg)